| abstract |
The invention relates to the use, in a composition or for the preparation of a composition, in a physiologically acceptable medium, of an effective amount of at least one inhibitor of -Hydroxy - MethylGlutaryl Coenzyme A-reductase (HMG CoA -reductase), the inhibitor or the composition being intended to treat seborrhea and the dermatoses which are associated therewith, in particular seborrheic dermatitis, blackheads and / or blackheads. |